Yanxin Pei

Children's National Hospital 
"Yanxin Pei"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Yu Y, Zhao Y, Choi J, et al. (2022) ERK Inhibitor Ulixertinib Inhibits High-Risk Neuroblastoma Growth In Vitro and In Vivo. Cancers. 14
Powell AB, Yadavilli S, Saunders D, et al. (2019) Medulloblastoma rendered susceptible to NK-cell attack by TGFβ neutralization. Journal of Translational Medicine. 17: 321
Tao R, Murad N, Xu Z, et al. (2019) MYC drives Group 3 medulloblastoma through transformation of Sox2+ astrocyte progenitor cells. Cancer Research
Staal JA, Pei Y, Rood BR. (2016) A Proteogenomic Approach to Understanding MYC Function in Metastatic Medulloblastoma Tumors. International Journal of Molecular Sciences. 17
Pei Y, Liu KW, Wang J, et al. (2016) HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC-Driven Medulloblastoma. Cancer Cell. 29: 311-323
Pham CD, Flores C, Yang C, et al. (2015) Differential immune microenvironments and response to immune checkpoint blockade amongst molecular subtypes of murine medulloblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Pei Y, Brun SN, Markant SL, et al. (2012) WNT signaling increases proliferation and impairs differentiation of stem cells in the developing cerebellum. Development (Cambridge, England). 139: 1724-33
Pei Y, Moore CE, Wang J, et al. (2012) An animal model of MYC-driven medulloblastoma. Cancer Cell. 21: 155-67
Pei Y, Wechsler-Reya RJ. (2010) A malignant oligarchy: progenitors govern the behavior of oligodendrogliomas. Cancer Cell. 18: 546-7
Gibson P, Tong Y, Robinson G, et al. (2010) Subtypes of medulloblastoma have distinct developmental origins. Nature. 468: 1095-9
See more...